Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer.
Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer.
复制标题
食管癌辐射引起的心包积液的剂量学预测因子。
DOI:
10.1007/s00066-017-1127-8
复制
发表时间:
2017
影响因子:
3.1
通讯作者:
Kimura K
中科院分区:
文献类型:
--
作者:
Ogino I;Watanabe S;Sakamaki K;Ogino Y;Kunisaki C;Kimura K
PurposeTo evaluate the dose–volume parameters of the pericardium and heart in order to reduce the risk of radiation-induced pericardial effusion (PE) and symptomatic PE (SPE) in esophageal cancer patients treated with concurrent chemoradiotherapy.MethodsIn 86 of 303 esophageal cancer patients, follow-up CT was obtained at least 24 months after concurrent chemoradiotherapy. Correlations between clinical factors, including risk factors for cardiac disease, dosimetric factors, and the incidence of PE and SPE after radiotherapy were analyzed using Cox proportional hazard regression analysis. Significant dosimetric factors with the highest hazard ratios were investigated using zones separated according to their distance from esophagus.ResultsPE developed in 49 patients. Univariate analysis showed the mean heart dose, heart V5–V55, mean pericardium dose, and pericardium V5–V50to all significantly affect the incidence of PE. Additionally, body surface area was correlated with the incidence of PE in multivariate analysis. Grade 3 and 4 SPE developed in 5 patients. The pericardium V50and pericardium D10significantly affected the incidence of SPE. The pericardium V50in patients with SPE ranged from 17.1 to 21.7%. Factors affecting the incidence of SPE were the V50of the pericardium zones within 3 cm and 4 cm of the esophagus.ConclusionA wide range of radiation doses to the heart and pericardium were related to the incidence of PE. A pericardium V50≤ 17% is important to avoid symptomatic PE in esophageal cancer patients treated with concurrent chemoradiotherapy.